Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Dysregulated Expression of Mirnas in Immune Thrombocytopenia Publisher Pubmed



Jafarzadeh A1, 2 ; Marzban H3 ; Nemati M4, 5 ; Jafarzadeh S6 ; Mahjoubintehran M7 ; Hamblin MR8 ; Mirzaei H9, 10 ; Mirzaei HR11
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Kerman University of Medical Sciences, Kerman, 76169-13555, Iran
  2. 2. Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, 7718175911, Iran
  3. 3. Department of Pathology and Experimental Animals, Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, 31975/148, Iran
  4. 4. Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, 77181/75911, Iran
  5. 5. Department of Hematology and Laboratory Sciences, School of Para-Medicine, Kerman University of Medical Sciences, Kerman, 76169-13555, Iran
  6. 6. Student Research Committee, School of Medicine, Kerman University of Medical Sciences, Kerman, 76169-13555, Iran
  7. 7. Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 13131- 99137, Iran
  8. 8. Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, 2028, South Africa
  9. 9. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, 87159-88141, Iran
  10. 10. Student Research Committee, Kashan University of Medical Sciences, Kashan, 87159-88141, Iran
  11. 11. Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, 1417613151, Iran

Source: Epigenomics Published:2021


Abstract

In recent years the critical role of miRNAs has been established in many diseases, including autoimmune disorders. Immune thrombocytopenia purpura (ITP) is a predominant autoimmune disease, in which aberrant expression of miRNAs has been observed, suggesting that miRNAs are involved in its development. miRNAs could induce an imbalance in the T helper (Th)1/Th2 cell and Th17/Treg cell-related responses. Moreover, they could also cause alterations in Th9 and Th22 cell responses, and activate Tfh (T follicular helper) cell-dependent auto-reactive B cells, thus influencing megakaryogenesis. Herein, we summarize the role of immune-related miRNAs in ITP pathogenesis, and look forward to clinical applications. © 2021 Future Medicine Ltd.